Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 35

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 35
---
 *        |
| All Current Directors and Current Officers (6 persons) |     |           38,847,462 |     | 20.3%    |
| Greater than 5% Shareholders (Not Listed Above)        |     |                      |     |          |
| Roivant Sciences Ltd.(8)                               |     |           38,847,462 |     | 20.3%    |
| Morgan Stanley(9)                                      |     |           21,524,661 |     | 11.2%    |
| Whitefort Capital Management, LP(10)                   |     |           13,307,967 |     | 7.0%     |
| Blackrock, Inc.(11)                                    |     |           10,390,300 |     | 5.4%     |

| * | Represents less than 1% of the outstanding Common Shares. |

| (1) | Beneficial ownership is determined in accordance with Rule 13d-3 under the Exchange Act. A person or group is deemed to be the beneficial owner of any Common Shares over which such person or group has sole or shared voting or investment power, plus any shares which such person or group has the right to acquire beneficial ownership of within 60 days of March 24, 2025, whether through the exercise of options or otherwise. Unless otherwise indicated in the footnotes, each person or entity identified in the table has sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. |

| (2) | The beneficial ownership percentage is calculated for each person or group separately because Common Shares subject to options or other rights to acquire our Common Shares that are currently exercisable or exercisable within 60 days of March 24, 2025 are considered outstanding only for the purpose of calculating the percentage ownership of the person or group holding such options or other rights but not for the purpose of calculating the percentage ownership of any other person or group. As a result, the beneficial ownership percentage for each person or group is calculated by dividing (x) the number of shares reported in the table as beneficially owned by such person or group, by (y) 191,480,188 Common Shares (which represents the number of Common Shares that were outstanding as of March 24, 2025) plus the number of shares that such person or group has the right to acquire beneficial ownership of within 60 days of March 24